BioCentury
ARTICLE | Company News

Illumina sales and marketing update

November 11, 2013 8:00 AM UTC

Illumina said its Verinata Health Inc. subsidiary's verifi prenatal test will be available to pregnant women in California through the state's Prenatal Screening Program. Through the program, the test will be offered to all pregnant women in California at increased risk of carrying a fetus with trisomy 21 or trisomy 18, or who have had an ultrasound showing a large nuchal translucency. The California Prenatal Screening Program is conducted through the California's Genetic Disease Screening Program. ...